Updated Review and Meta-Analysis of Probiotics for the Treatment of Clinical Depression: Adjunctive vs. Stand-Alone Treatment
Open accessThe DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Abstract
Recent years have seen a rapid increase in the use of gut microbiota-targeting interventions, such as probiotics, for the treatment of psychiatric disorders. The objective of this update review was to evaluate all randomised controlled clinical trial evidence on the efficacy of probiotics for clinical depression. Cochrane guidelines for updated reviews were followed. By searching PubMed and Web of Science databases, we identified 546 new records since our previous review. A total of seven studies met selection criteria, capturing 404 people with depression. A random effects meta-analysis using treatment type (stand-alone vs. adjunctive) as subgroup was performed. The results demonstrated that probiotics are effective in reducing depressive symptoms when administered in addition to antidepressants (SMD = 0.83, 95%CI 0.49–1.17), however, they do not seem to offer significant benefits when used as stand-alone treatment (SMD = −0.02, 95%CI −0.34–0.30). Potential mechanisms of action may be via increases in brain-derived neurotrophic factor (BDNF) and decreases in C-reactive protein (CRP), although limited evidence is available at present. This review offers stronger evidence to support the clinical use of probiotics in depressed populations and provides an insight into the mode of administration more likely to yield antidepressant effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) study flow diagram for updated reviews. Adapted from Stovold et al. [25].](https://figures.cochat.ai/paper-figures/270ca885976b49c79212cf3fee4c2f7c/updated-review-and-meta-analysis-of-probiotics-for-the-treatment-of-clinical-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Probiotics have been recently tested to re-establish a healthy microbial status, due to their ability to balance the dysbiosis created under the depressive state [117].”
From Antimicrobial Properties of Antidepressants and Antipsychotics—Possibilities and Implications (2021) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [16]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recent meta-analyses have shown a little overall effect on several pooled outcomes regarding mental health [1,6,15,16], concluding that an optimal psychobiotic recommendation in terms of dosage, strains, and duration cannot yet be conceived.”
From Psychobiotic effects on anxiety are modulated by lifestyle behaviors: a randomized placebo-controlled trial on healthy adults (2023) · cites this paper as [16]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Cochrane Handbook for Systematic Reviews of Interventions
(2019) · doi:10.1002/9781119536604 · Cited by 14,828
James, S. L., Abate, D., Abate, K. H., Abay, S. M., Abbafati, C., Abbasi, N., Abbastabar, H., Abd-Allah, F., Abdela, J., Abdelalim, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32279-7 · Cited by 13,867
Vos, T., Abajobir, A. A., Abate, K. H., Abbafati, C., Abbas, K. M., Abd-Allah, F., Abdulkader, R. S., Abdulle, A. M., Abebo, T. A., Abera, S. F., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)32154-2 · Cited by 13,220
Sterne, J. A. C., Sutton, A. J., Ioannidis, J. P. A., Terrin, N., Jones, D. R., Lau, J., Carpenter, J., Rucker, G., Harbord, R. M., Schmid, C. H., et al. (2011) · BMJ · doi:10.1136/bmj.d4002 · Cited by 7,709 · cited 1×
“Due to the low number of studies, and in accordance with published recommendations [24], we did not perform additional sensitivity analyses, meta-regression, or assessment of publication bias.”
ResultMind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
Zheng, P., Zeng, B., Zhou, C., Liu, M., Fang, Z., Xu, X., Zeng, L., Chen, J., Fan, S., Du, X., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.44 · Cited by 2,023 · cited 1×
“For example, a recent study in rats found that the NMDA receptor antagonist ketamine amplifies levels of the genus Lactobacilli [44], which has been found to be reduced in depressed animals, with some evidence of decreases in clinical populations as well [45,46].”
BackgroundThe neuroactive potential of the human gut microbiota in quality of life and depression
Valles-Colomer, M., Falony, G., Darzi, Y., Tigchelaar, E. F., Wang, J., Tito, R. Y., Schiweck, C., Kurilshikov, A., Joossens, M., Wijmenga, C., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0337-x · Cited by 1,963
Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · cited 1×
“Other probiotic formulations have also been found to increase hippocampal BDNF in mice [12,54,55].”
BackgroundRaison, C. L., Rutherford, R. E., Woolwine, B. J., Shuo, C., Schettler, P., Drake, D. F., Haroon, E., & Miller, A. H. (2013) · JAMA Psychiatry · doi:10.1001/2013.jamapsychiatry.4 · Cited by 1,617 · cited 1×
“A study of antidepressant non-responders reported that CRP was elevated in nearly half the population [56].”
BackgroundDiagnosis and definition of treatment-resistant depression
Fava, M. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00231-2 · Cited by 1,380 · cited 1×
“It has been estimated that up to 60% of patients with MDD experience some degree of non-response to the wide range of pharmacological treatments [4], which predominantly target monoamine dysregulation in the brain.”
BackgroundBacterial infection causes stress-induced memory dysfunction in mice
Gareau, M. G., Wine, E., Rodrigues, D. M., Cho, J. H., Whary, M. T., Philpott, D. J., MacQueen, G., & Sherman, P. M. (2011) · Gut · doi:10.1136/gut.2009.202515 · Cited by 909 · cited 1×
“Other probiotic formulations have also been found to increase hippocampal BDNF in mice [12,54,55].”
BackgroundAkkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M. R., Asemi, Z., & Esmaillzadeh, A. (2016) · Nutrition · doi:10.1016/j.nut.2015.09.003 · Cited by 767 · cited 7×
“CRP Akkasheh (2015) [28] Significantly reduced in the probiotic group compared to placebo post-treatment.”
BackgroundResultInfluentialLamers, F., Vogelzangs, N., Merikangas, K. R., de Jonge, P., Beekman, A. T. F., & Penninx, B. W. J. H. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.144 · Cited by 691
Systematic Review of Gut Microbiota and Major Depression
Cheung, S. G., Goldenthal, A. R., Uhlemann, A.-C., Mann, J. J., Miller, J. M., & Sublette, M. E. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00034 · Cited by 597
Aizawa, E., Tsuji, H., Asahara, T., Takahashi, T., Teraishi, T., Yoshida, S., Ota, M., Koga, N., Hattori, K., & Kunugi, H. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.05.038 · Cited by 576
Kazemi, A., Noorbala, A. A., Azam, K., Eskandari, M. H., & Djafarian, K. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2018.04.010 · Cited by 534 · cited 5×
“Other tryptophan ratios Kazemi (2019) [29] Tryptophan/isoleucine ratio significantly reduced in the probiotic group compared to the placebo group post-treatment.”
BackgroundMethodInfluentialRudzki, L., Ostrowska, L., Pawlak, D., Małus, A., Pawlak, K., Waszkiewicz, N., & Szulc, A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.10.010 · Cited by 499 · cited 9×
“Other kynurenine ratios Rudzki (2019) [30] 3HKYN/KYN ratio significantly decreased in the probiotic group compared to the placebo group post-treatment.”
BackgroundInfluentialSvanborg, P., & Åsberg, M. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(00)00242-1 · Cited by 481
Ait‐Belgnaoui, A., Colom, A., Braniste, V., Ramalho, L., Marrot, A., Cartier, C., Houdeau, E., Theodorou, V., & Tompkins, T. (2014) · Neurogastroenterology & Motility · doi:10.1111/nmo.12295 · Cited by 434
When and how to update systematic reviews: consensus and checklist
Garner, P., Hopewell, S., Chandler, J., MacLehose, H., Schünemann, H. J., Akl, E. A., Beyene, J., Chang, S., Churchill, R., Dearness, K., et al. (2016) · BMJ · doi:10.1136/bmj.i3507 · Cited by 426 · cited 1×
“We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) [18] guidelines, as well as guidance on performing updated reviews [19,20].”
MethodMelancholic microbes: a link between gut microbiota and depression
Dinan, T. G., & Cryan, J. F. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12198 · Cited by 424
Biomarkers for depression: recent insights, current challenges and future prospects
Strawbridge, R., Young, A. H., & Cleare, A. J. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s114542 · Cited by 415 · cited 3×
“Attenuations in serum levels of the growth factor BDNF have been linked to depression, and importantly, to antidepressant response [5].”
BackgroundInfluentialSelf-citationGut microbiota and major depressive disorder: a systematic review and meta-analysis
Sanada, K., Nakajima, S., Kurokawa, S., Barceló-Soler, A., Ikuse, D., Hirata, A., Yoshizawa, A., Tomizawa, Y., Salas-Valero, M., Noda, Y., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.102 · Cited by 372
Impact of pain on depression treatment response in primary care
Bair, M. J., Robinson, R. L., Eckert, G. J., Stang, P. E., Croghan, T. W., & Kroenke, K. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000106883.94059.c5 · Cited by 371
Study flow diagrams in Cochrane systematic review updates: an adapted PRISMA flow diagram
Stovold, E., Beecher, D., Foxlee, R., & Noel-Storr, A. (2014) · Systematic Reviews · doi:10.1186/2046-4053-3-54 · Cited by 356
Romijn, A. R., Rucklidge, J. J., Kuijer, R. G., & Frampton, C. (2017) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867416686694 · Cited by 323
The gut microbiome composition associates with bipolar disorder and illness severity
Evans, S. J., Bassis, C. M., Hein, R., Assari, S., Flowers, S. A., Kelly, M. B., Young, V. B., Ellingrod, V. E., & McInnis, M. G. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.12.007 · Cited by 304
Macedo, D., Filho, A. J. M. C., Soares de Sousa, C. N., Quevedo, J., Barichello, T., Júnior, H. V. N., & Freitas de Lucena, D. (2017) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.09.012 · Cited by 261
Chahwan, B., Kwan, S., Isik, A., van Hemert, S., Burke, C., & Roberts, L. (2019) · Journal of Affective Disorders · doi:10.1016/j.jad.2019.04.097 · Cited by 256
Shilyansky, C., Williams, L. M., Gyurak, A., Harris, A., Usherwood, T., & Etkin, A. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00012-2 · Cited by 249 · cited 1×
“For example, SSRIs have been found to be less effective for the treatment of anhedonia [47,48] and somatic presentations [49], while both SSRIs and SNRIs have shown limited efficacy for cognitive impairment [47,50] and anxious depression [51].”
BackgroundInteraction Between Atypical Antipsychotics and the Gut Microbiome in a Bipolar Disease Cohort
Flowers, S. A., Evans, S. J., Ward, K. M., McInnis, M. G., & Ellingrod, V. L. (2017) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1890 · Cited by 235 · cited 1×
“[43] found that in adults with bipolar disorder atypical antipsychotics significantly decreased bacterial species known to have beneficial anti-inflammatory properties.”
BackgroundFava, M., Graves, L. M., Benazzi, F., Scalia, M. J., Iosifescu, D. V., Alpert, J. E., & Papakostas, G. I. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n1113 · Cited by 229
Getting What You Ask For: On the Selectivity of Depression Rating Scales
Demyttenaere, K., & De Fruyt, J. (2003) · Psychotherapy and Psychosomatics · doi:10.1159/000068690 · Cited by 206 · cited 1×
“, MADRS, HAMD-17, BDI), have been criticised for lack of sensitivity towards atypical presentations [53], as they do not cover the full range of symptoms and measure only unilateral change (e.”
BackgroundAntidepressive Mechanisms of Probiotics and Their Therapeutic Potential
Yong, S. J., Tong, T., Chew, J., & Lim, W. L. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01361 · Cited by 204
Miyaoka, T., Kanayama, M., Wake, R., Hashioka, S., Hayashida, M., Nagahama, M., Okazaki, S., Yamashita, S., Miura, S., Miki, H., et al. (2018) · Clinical Neuropharmacology · doi:10.1097/wnf.0000000000000299 · Cited by 186
Unravelling the antimicrobial action of antidepressants on gut commensal microbes
Ait Chait, Y., Mottawea, W., Tompkins, T. A., & Hammami, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-74934-9 · Cited by 153
Husain, M. I., Chaudhry, I. B., Husain, N., Khoso, A. B., Rahman, R. R., Hamirani, M. M., Hodsoll, J., Qurashi, I., Deakin, J. F., & Young, A. H. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117724352 · Cited by 144
Self-citationAugmentation therapies for treatment-resistant depression: systematic review and meta-analysis
Strawbridge, R., Carter, B., Marwood, L., Bandelow, B., Tsapekos, D., Nikolova, V. L., Taylor, R., Mantingh, T., de Angel, V., Patrick, F., et al. (2019) · British Journal of Psychiatry · doi:10.1192/bjp.2018.233 · Cited by 140
Self-citationGetachew, B., Aubee, J. I., Schottenfeld, R. S., Csoka, A. B., Thompson, K. M., & Tizabi, Y. (2018) · BMC Microbiology · doi:10.1186/s12866-018-1373-7 · Cited by 134
Ghorbani, Z., Nazari, S., Etesam, F., Nourimajd, S., Ahmadpanah, M., & Razeghi Jahromi, S. (2018) · Archives of Neuroscience · doi:10.5812/archneurosci.60507 · Cited by 127
Amirani, E., Milajerdi, A., Mirzaei, H., Jamilian, H., Mansournia, M. A., Hallajzadeh, J., & Ghaderi, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2020.102361 · Cited by 113
Depression, antidepressant medications, and risk of Clostridium difficileinfection
Rogers, M. A., Greene, M. T., Young, V. B., Saint, S., Langa, K. M., Kao, J. Y., & Aronoff, D. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-121 · Cited by 101
O'Sullivan, E., Barrett, E., Grenham, S., Fitzgerald, P., Stanton, C., Ross, R., Quigley, E., Cryan, J., & Dinan, T. (2011) · Beneficial Microbes · doi:10.3920/bm2011.0015 · Cited by 92
Vaghef-Mehrabany, E., Maleki, V., Behrooz, M., Ranjbar, F., & Ebrahimi-Mameghani, M. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2019.06.004 · Cited by 89
Psychobiotics as treatment for anxiety, depression, and related symptoms: a systematic review
Smith, K. S., Greene, M. W., Babu, J. R., & Frugé, A. D. (2019) · Nutritional Neuroscience · doi:10.1080/1028415x.2019.1701220 · Cited by 88
Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking
Furukawa, T. A., Reijnders, M., Kishimoto, S., Sakata, M., DeRubeis, R. J., Dimidjian, S., Dozois, D. J. A., Hegerl, U., Hollon, S. D., Jarrett, R. B., et al. (2020) · Epidemiology and Psychiatric Sciences · doi:10.1017/s2045796019000088 · Cited by 86
Heidarzadeh-Rad, N., Gökmen-Özel, H., Kazemi, A., Almasi, N., & Djafarian, K. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20079 · Cited by 86
Kazemi, A., Noorbala, A. A., Azam, K., & Djafarian, K. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2018.11.041 · Cited by 67
Nikolova, V., Zaidi, S. Y., Young, A. H., Cleare, A. J., & Stone, J. M. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319859963 · Cited by 66
Self-citationPharmacologic Treatment of Dimensional Anxious Depression: A Review
Ionescu, D. F., Niciu, M. J., Richards, E. M., & Zarate, C. A. (2014) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.13r01621 · Cited by 56 · cited 1×
“For example, SSRIs have been found to be less effective for the treatment of anhedonia [47,48] and somatic presentations [49], while both SSRIs and SNRIs have shown limited efficacy for cognitive impairment [47,50] and anxious depression [51].”
BackgroundRios, A. C., Maurya, P. K., Pedrini, M., Zeni-Graiff, M., Asevedo, E., Mansur, R. B., Wieck, A., Grassi-Oliveira, R., McIntyre, R. S., Hayashi, M. A. F., et al. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0001 · Cited by 45
Kazemi, A., Noorbala, A. A., & Djafarian, K. (2020) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12675 · Cited by 42
Husain, M. I., Cullen, C., Umer, M., Carvalho, A. F., Kloiber, S. M., Meyer, J. H., Ortiz, A., Knyahnytska, Y., Husain, M. O., Giddens, J. L., et al. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02553-9 · Cited by 29
Self-citationYee, A. H. A., Chin, S. C., Hashim, A. H., Singh, M. K. A. P. H., Loh, H. S., Sulaiman, A. H., & Ng, C. G. (2015) · International Journal of Psychiatry in Clinical Practice · doi:10.3109/13651501.2015.1031139 · Cited by 19
Hirschberg, R. R., Cohen, A. H., & Kopple, J. D. (2008) · American Journal of Nephrology · doi:10.1159/000167553 · Cited by 10
Research works printed but not linked: 2
- Cumpston, M., and Changler, J. Chapter IV: Updating a review. Cochrane Handbook for Systematic Reviews of Interventions Version 6.1, Cochrane. Available online: https://training.cochrane.org/handbook/current/chapter-iv.
- Ionescu, 2014, Pharmacologic Treatment of Dimensional Anxious Depression, Prim. Care Companion CNS Disord., 16, PCC.13r01621
Cited by
Schaub, A.-C., Schneider, E., Vazquez-Castellanos, J. F., Schweinfurth, N., Kettelhack, C., Doll, J. P. K., Yamanbaeva, G., Mählmann, L., Brand, S., Beglinger, C., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01977-z · Cited by 242
Chen, L.-M., Bao, C.-H., Wu, Y., Liang, S.-H., Wang, D., Wu, L.-Y., Huang, Y., Liu, H.-R., & Wu, H.-G. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02175-2 · Cited by 227
Yin, Y., Ju, T., Zeng, D., Duan, F., Zhu, Y., Liu, J., Li, Y., & Lu, W. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107322 · Cited by 178
Nikolova, V. L., Cleare, A. J., Young, A. H., & Stone, J. M. (2023) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2023.1817 · Cited by 140
Self-citationJohnson, D., Thurairajasingam, S., Letchumanan, V., Chan, K., & Lee, L. (2021) · Nutrients · doi:10.3390/nu13051728 · Cited by 138
Metadata
- Authors
- Nikolova, V., Cleare, A., Young, A., & Stone, J.
- Affiliations
- King's College London (GB)
- Brighton and Sussex Medical School (GB)
- Corresponding author
- Nikolova, Viktoriya
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2021-02-08
- Volume
- 10
- Issue
- 4
- Pages
- 647
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC7915600
- OpenAlex
- W3126375840
- Cited by
- 106
- References
- 58
- Citations by year
- 2026: 19 · 2025: 21 · 2024: 14 · 2023: 26 · 2022: 13 · 2021: 12
- FWCI
- 1.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Sussex Research Online (University of Sussex) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institute for Health and Care Research (NF-SI-0616-10091, NIHR202380)
- Medical Research Council (2171139)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, major depressive disorder, adjunctive therapy, antidepressants, gut microbiota, depressive symptoms, brain-derived neurotrophic factor, C-reactive protein, antidepressant efficacy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.